CONFORM: Rotational Fractional Resection for Submental Contouring

NCT ID: NCT03407313

Last Updated: 2021-02-03

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-08

Study Completion Date

2019-04-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the safety and efficacy of rotational fractional resection (RFR) to improve neck contouring. RFR is used to remove loose skin and fat.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, multi-center, single-arm (non-randomized), interventional cohort, non-significant risk (NSR) study designed to investigate the efficacy and safety of Rotational Fractional Resection (skin resection and focal lipectomy) in patients with mild to moderate submental fat and mild to moderate submental skin laxity. The total duration of study participation for each subject is approximately up to 7 months for each subject from the screening visit to the exit visit. The follow-up period will be approximately 6 months after the procedure. Eligible subjects will complete a total of 8 study visits: screening, procedure, and follow-up visits at 1, 7, 14, 30, 90 and 180 days post-procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Laxity Lipodystrophy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Rotational fractional resection (1.5mm diameter device)

Single treatment of skin resection and focal lipectomy (removal of loose skin and fat)

Group Type EXPERIMENTAL

Rotational fractional resection (1.5mm diameter device)

Intervention Type DEVICE

Single treatment of skin resection and focal lipectomy (removal of loose skin and fat)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rotational fractional resection (1.5mm diameter device)

Single treatment of skin resection and focal lipectomy (removal of loose skin and fat)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy male or female, at least 30 years old
* Moderate submental (neck) fat
* Mild to moderate submental (neck) skin laxity (loose skin)
* Willing and able to provide informed consent
* Willing and able to comply with all protocol requirements
* Willing to limit direct sun exposure and use sunscreen for duration of the study
* Agree to maintain weight for duration of the study
* Willing to have photographs taken that could identify the participant

Exclusion Criteria

* Previous intervention to treat submental fat or skin laxity
* Use of aspirin, ibuprofen, naproxen, or Vitamin E within 14 days of the procedure
* Sensitivity to local anesthesia
* Severe acne, cystic acne or acne scars on neck
* Trauma of chin or neck area
* Skin infection or rash on neck
* Psoriasis, eczema, rosacea, or vitiligo
* History of scarring
* History or current symptoms of dysphagia
* Chronic or persistent coughing
* Body mass index (BMI) \> 30
* Clinically significant bleeding disorder
* Anemia, kidney disease, or liver disease
Minimum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Recros Medica, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Edward W Knowlton, MD

Role: STUDY_DIRECTOR

Recros Medica, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Aesthetx

Campbell, California, United States

Site Status

Steve Yoelin, MD Medical Associates, Inc.

Newport Beach, California, United States

Site Status

Roseville Facial Plastic Surgery

Roseville, California, United States

Site Status

Miami Dermatology & Laser Institute

Miami, Florida, United States

Site Status

DeNova Research

Chicago, Illinois, United States

Site Status

Sundaram Dermatology, Cosmetic & Laser Surgery Center

Fairfax, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLP-0002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

GalaFlex Mesh in Facelift
NCT02053831 COMPLETED